Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. RH
5. SPY
6. NVDA
7. MSFT
8. MH
9. DLMAF
10. DOL:CN

Go back to Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy

Sangamo BioSciences (SGMO) PT Raised to $6 at Wedbush

May 16, 2017 8:45 AM EDT

Wedbush raised its price target on Sangamo BioSciences (NASDAQ: SGMO) to $6.00 (from $4.00) while maintaining a Neutral rating. Analyst Liana Moussatos views Pfizer as a long-term positive for the Hemophilia A program.

Management reiterated plans to release clinical data from its SB-FIX for... More